Pricing Log in Create free account

Kymera Therapeutics, Inc. (KYMR) vs Vaxcyte, Inc. (PCVX)

Kymera Therapeutics, Inc. and Vaxcyte, Inc. are both Biotechnology companies. Kymera Therapeutics, Inc. is the larger, with a market value of $10.9B against $9.8B — 1.1× the size. Across the 11 metrics below, Kymera Therapeutics, Inc. leads on 8 and Vaxcyte, Inc. on 3.

Valuation

Metric KYMR PCVX Biotechnology median
P/E n/m n/m 10.26
P/S 119.82 n/m 9.18
P/B 7.79 3.28 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 110.58 n/m 8.98
Earnings yield (2.88%) (12.20%) (34.89%)
Free cash flow yield (2.30%) (9.89%) (24.52%)

Profitability

Metric KYMR PCVX Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (27.29%) (36.51%) (50.12%)
Return on assets (24.36%) (33.03%) (45.60%)
Return on invested capital (39.30%) (57.30%) 0.00%

Growth

Metric KYMR PCVX Biotechnology median
Revenue growth (TTM) 134.84% — 6.26%
EPS growth (last fiscal year) (23.83%) (48.16%) 29.88%
Revenue growth, 5-year CAGR 2.87% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KYMR PCVX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.13 5.72 4.89
Net debt to EBITDA 2.42 1.71 1.01

Dividend

Metric KYMR PCVX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KYMR PCVX Biotechnology median
Market cap 10.94b 9.75b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack